Back to top
more

The Cooper Companies (COO)

(Delayed Data from NSDQ)

$102.00 USD

102.00
1,798,381

-1.55 (-1.50%)

Updated Nov 12, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth D Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (85 out of 250)

Industry: Medical - Dental Supplies

Zacks News

Will The Cooper Companies (COO) Beat Estimates Again in Its Next Earnings Report?

The Cooper Companies (COO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here's Why You Should Retain Cooper Companies (COO) Stock Now

Cooper Companies (COO) continues to benefit from strength in its business segments.

Cooper Companies (COO) Unit's MiSight Gets Approval in China

CooperVision, a unit of Cooper Companies (COO), receives approval for MiSight 1 day contact lenses from China's National Medical Products Administration for use in China.

Here's Why You Should Retain Abiomed (ABMD) Stock for Now

Investors continue to be optimistic about Abiomed (ABMD) owing to its strength in the Impella product line.

Strength Seen in The Cooper Companies (COO): Can Its 7.8% Jump Turn into More Strength?

The Cooper Companies (COO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

HSIC vs. COO: Which Stock Is the Better Value Option?

HSIC vs. COO: Which Stock Is the Better Value Option?

Trina Mukherjee headshot

3 Stocks to Tap the Promising Dental Supplies Industry

Despite the COVID-19 pandemic induced challenges, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical-Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

HSIC vs. COO: Which Stock Should Value Investors Buy Now?

HSIC vs. COO: Which Stock Is the Better Value Option?

HSIC vs. COO: Which Stock Should Value Investors Buy Now?

HSIC vs. COO: Which Stock Is the Better Value Option?

Cooper Companies (COO) Q2 Earnings Top Estimates, '21 View Up

Cooper Companies' (COO) fiscal second-quarter 2021 earnings reflect solid segmental performance.

Abbott (ABT) Downgrades 2021 Outlook on Lower Testing Demand

Abbott's (ABT) revised 2021 forecast continues to reflect strong, double-digit EPS growth despite lower COVID-19 testing demand.

Myriad Genetics (MYGN) Sells myPath to Focus on Core Units

Myriad Genetics' (MYGN) new divesture will provide the company with growth capital for future investments.

Quest Diagnostics (DGX) Buys Outreach Lab, Widens Midwest Base

Mercy's outreach laboratory services are set to get integrated into Quest Diagnostics' (DGX) full-service laboratory in Lenexa, KS.

Integra (IART) Tissue Technologies Rebounds Amid Supply Woe

Integra's (IART) CSS segment too reflects a gradual recovery in procedure-based market as well as an improvement in hospital capital spending during the first quarter.

Walgreens' (WBA) New Partnerships Aid, Retail Sales Dip

Walgreens Boots' (WBA) response toward combatting the pandemic - conducting COVID-19 tests at various locations and actively participating in vaccinating residents and staff - is impressive.

Illumina (ILMN) Expands NIPT Offering With New Collaboration

Illumina's (ILMN) VeriSeq NIPT Solution v2 provides accurate, consistent and scalable end-to-end genome-wide noninvasive prenatal testing.

Cooper Companies (COO) Unit's Ortho-K Lens Receives CE Mark

Cooper Companies' (COO) unit CooperVision's latest orthokeratology contact lens becomes the latest myopia control product to gain European approval.

Here's Why You Should Add STERIS (STE) to Your Portfolio

Investors are optimistic about STERIS (STE) owing to strong segmental performance and huge growth potential in healthcare and pharmaceutical industries.

Cooper Companies (COO) to Post Q2 Earnings: What's in Store?

Cooper Companies' (COO) fiscal second-quarter results are likely to reflect segmental strength.

Myriad Genetics' (MYGN) GeneSight Test Rollout Initiated by IPM

Myriad Genetics' (MYGN) GeneSight testing distribution initiated through IPM will help clinicians and patients assess individual's response to certain medications.

The Cooper Companies (COO) Reports Next Week: Wall Street Expects Earnings Growth

The Cooper Companies (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The Cooper Companies (COO) Upgraded to Buy: What Does It Mean for the Stock?

The Cooper Companies (COO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Masimo (MASI), Spacelabs Team Up to Enhance Patient Outcome

Masimo's (MASI) extension of partnership with Spacelabs is expected to provide better patient outcomes with the accessibility of patient monitoring solutions.

Here's Why You Should Add Inogen (INGN) to Your Portfolio

Investors continue to be optimistic about Inogen (INGN) on its direct-to-customer business model and a strong product portfolio.

Veeva (VEEV) Enhances Clinical Trial Management via Vault CTMS

Veeva's (VEEV) Vault CTMS application is expected to aid global organizations to advance study execution while ensuring compliance.